NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Envoy Medical, Inc. (COCH) Stock Analysis

Envoy Medical, Inc. (COCH) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

COCH

$0.65

+$0.01 (+1.99%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare COCH with… →

COCH Key Statistics

As of Oct 21, 2026
Trading
Open
$0.64
Previous Close
$0.63
Day's Range
0.63–0.68
52-Week Range
0.36–0.95
Volume
72.14K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.95
Valuation
Market Cap
$48.98M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
236.62
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.76
Financials (FY)
Revenue (FY)
$241.00K+7.11%
Net Income (FY)
−$23.76M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
77.19M
1-Year Return
−24.67%
Dividend and dates
Avg Volume
98.56K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, COCH closed at $0.65, −24.67% over 1 year.

Envoy Medical, Inc. (COCH) has a market capitalization of $48.98M.

In fiscal 2025, COCH reported revenue of $241.00K.

COCH Stock Return by Calendar Year

Envoy Medical, Inc. (COCH) return since Apr 2021: what $10,000 became

1 year
$10,000 $7,533
−24.67%
5 years
$10,000 $665
−93.35%
Since Apr 2021
$10,000 $663
−93.37%

If you had invested $10,000 in Envoy Medical, Inc. (COCH) at the close on April 29, 2021, the earliest close on record here, it would have been worth $663 at the close on October 21, 2026: −93.37% in total, −39.06% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−2.10%
2025−53.78%
2024−21.04%
2023−81.93%
2022+2.87%
2021 (partial year)−0.20%

As of October 21, 2026.

COCH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$241.00K−$23.76M−9,857.3%
2024$225.00K−$20.80M−9,242.2%
2023$316.00K−$29.92M−9,469.0%
2022$237.00K−$15.92M−6,718.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$241.00K−$633.00K−$22.27M−$23.76M−9,857.3%
2024$225.00K−$517.00K−$19.26M−$20.80M−9,242.2%
2023$316.00K−$473.00K−$18.36M−$29.92M−9,469.0%
2022$237.00K−$261.00K−$8.71M−$15.92M−6,718.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

COCH Valuation vs Medical Devices Median

Median of 145 stocks
MetricCOCHMedical Devices medianvs median
P/S ratio236.622.5393.5x the median

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 14 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Envoy Medical, Inc. (COCH) at $48.98M. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 43 employees.

The 52-week range on file runs from $0.36 to $0.95. COCH last closed at $0.65 on October 21, 2026. That is +$0.01 (+1.99%) against the previous close. The latest close sits 78.26% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $241.00K. Against the prior fiscal year total of $225.00K, that is a change of +7.11%. The same year closed with a net loss of $23.76M. Trailing earnings per share are −0.76.

Across the 4 fiscal years on file, revenue moves from $237.00K in 2022 to $241.00K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 236.62 times revenue. On price-to-sales that is 93.5 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −24.67%. Across 5 years the annualized return works out at −41.85%. Beta against the wider market is reported at 1.95. Annualized volatility over the trailing 5 years is 136.27%.

Growth & Income

The record shows no dividend for COCH.

The strongest complete calendar year on file is 2022 at +2.87%; the weakest is 2023 at −81.93%. Of the 4 complete calendar years on file, 1 finished higher. So far in 2026 the total return is −2.10%.

Peer Comparison

Envoy Medical, Inc. (COCH) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Envoy Medical, Inc. COCH $48.98M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Envoy Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Envoy Medical, Inc.

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Visit website →